Results 141 to 150 of about 10,163 (201)

Site-Specific Glycan Conjugation Improves Stability and Efficacy of an Antibody-Drug Conjugates Bearing DXd as a Cytotoxic Payload. [PDF]

ACS Omega
Manabe S, Senga S, Iwamoto S, Yarita H, Takahashi R, Mitani A, Sumiyoshi W, Hoshinoo A, Hiranyakorn M, Kinoshita T, Yoshimura C.   +10 more
europepmc   +1 more source

Distinct Antibody Fc-profiles in Lymph During Homeostasis and Chronic HIV Infection. [PDF]

Pathog Immun
McNamara RP, Butler AL, Dolatshahi S, Taylor S, Dori Y, Frank I, Itkin MG, Betts MR, Alter G.   +8 more
europepmc   +1 more source

Universal broad-spectrum mucosal vaccine design for human coronaviruses inspired by artificial antibodies. [PDF]

NPJ Vaccines
Wu Y, Lu J, Fang L, Chen X, Zhao C, Zhang Z, Zhu X, Gao X, Li H, Yan Y, Shi J, Zhang J, Zhou P, Pan X.   +13 more
europepmc   +1 more source

Pharmacovigilance analysis of FcRn antagonists in the treatment of myasthenia gravis: A disproportionality analysis based on the FAERS database. [PDF]

Hum Vaccin Immunother
Liu B, Zhang W, Chen Y, Han A, Chen D.
europepmc   +1 more source

Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance. [PDF]

Front Immunol
Remaily BC, Young G, Lathrop H, Thomas J, Kim K, Vu TT, Adeluola A, Stanton C, Mulcahy G, Xie Z, Granchie L, Guo Y, Hai M, Wedig J, Schmidt M, Manna M, Mo X, Lowe J, Rafael-Fortney JA, Folefac E, Gregorevic P, Owen DH, Kulp SK, Ganesan LP, Coss CC, Mace TA, Phelps MA.   +26 more
europepmc   +1 more source

Nipocalimab-aahu in generalised myasthenia gravis: A new Fc receptor-targeted option for antibody-positive patients. [PDF]

Ibrain
Hussain JM, Ashfaq A, Shahid A, Mudassir F.   +3 more
europepmc   +1 more source

Albumin Levels Are Predictive of Cachexia-Induced Time-Dependent Clearance of Therapeutic Antibodies: A Physiologically Based Pharmacokinetic Model of Durvalumab. [PDF]

CPT Pharmacometrics Syst Pharmacol
Proctor JR, Wong H.
europepmc   +1 more source

What has changed in thyroid eye disease in the last five years (2020-2025). [PDF]

Eur Thyroid J
Salvi M.
europepmc   +1 more source